A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Clinical trial NCT07654374 · RECRUITING

Trial details

NCT number: NCT07654374
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Chronic Weight Management Type2 Diabetes Mellitus

Start date: 2026-07-17
Primary completion: 2028-09-01
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.